SALT LAKE CITY–(BUSINESS WIRE)–Teiko, a CLIA clinical laboratory focused on monitoring the immune response, today announced that the Company will present four posters at the Society for Immunotherapy of Cancer’s (SITC) 41st Annual Meeting.Stabilized Whole Blood from Patients with CancerTitle: Enhanced Preservation of Real-World Diseased Immune Signatures in Stabilized Whole Blood Enables Longitudinal Studies of Multiparameter Immune MonitoringPresenting Author(s): Chaoyuan Kuang, MD, PhD, Albe
